Clinical Trials
3 trialsNCT07560410 2026-05-11
Treatment of Truncated ALK-positive Bone Cancer Using Crizotinib (Xalkori) or Alectinib (Alecensa)
China Medical University Hospital
Phase 1/2 Not yet recruiting
NCT06709274 2024-11-29
MOTION-NSCLC
Guangdong Association of Clinical Trials
Phase NA Not yet recruiting
NCT06692491 2024-11-18
SPRING
Peking University Shenzhen Hospital
Phase 2 Not yet recruiting